Titre:
  • The impact of new European Organisation for Research and Treatment of Cancer guidelines on the use of granulocyte colony-stimulating factor on the management of breast cancer patients.
Auteur:Zielinski, Christoph C; Awada, Ahmad; Cameron, David A; Cufer, T; Martin, Miguel; Aapro, Matti
Informations sur la publication:European journal of cancer, 44, 3, page (353-365)
Statut de publication:Publié, 2008-02
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:Breast cancer
EORTC
European
Febrile neutropenia
G-CSF
Granulocyte colony-stimulating factor
MeSH keywords:Aged
Antineoplastic Agents -- adverse effects
Breast Neoplasms -- drug therapy
Dose-Response Relationship, Drug
Drug Administration Schedule
Evidence-Based Medicine
Female
Granulocyte Colony-Stimulating Factor -- administration & dosage
Humans
Middle Aged
Neutropenia -- chemically induced
Neutropenia -- prevention & control
Practice Guidelines as Topic
Risk Assessment
Risk Factors
Treatment Outcome
Note générale:Journal Article
Review
Langue:Anglais
Identificateurs:urn:issn:0959-8049
info:doi/10.1016/j.ejca.2007.11.024
info:pii/S0959-8049(07)00969-0
info:scp/39149083085
info:pmid/18191396